Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep 1;8(9):930.
doi: 10.3390/jof8090930.

Paecilomyces/ Purpureocillium Infection in Children, Case Report, and Review of the Literature

Affiliations
Case Reports

Paecilomyces/ Purpureocillium Infection in Children, Case Report, and Review of the Literature

Musaed Alharbi et al. J Fungi (Basel). .

Abstract

Paecilomyces/Purpureocillium has recently been recognized as an emerging human pathogen, causing serious infection in immunocompromised and immunocompetent patients. Several predisposing factors have been reported, including foreign body implants, previous surgery, or trauma. Treatment with antifungal drugs often fails as species-specific differences in antifungal susceptibilities are one of the management challenges. Surgical debridement with or without antifungal therapy was sufficient to cure the infection in a few reported cases. Nonetheless, the surgical approach has been found to decrease the chance of dissemination and recurrence. Here, we report the first pediatric patient with chronic osteomyelitis of the femur secondary to Paecilomyces species, with no predisposing risk factors. Our case was successfully treated with a combination of antifungal therapy and surgical debridement. Additionally, we describe the first extensive literature review of previously reported Paecilomyces/Purpureocillium species infections in pediatric age groups.

Keywords: Paecilomyces; Purpureocillium; fungal; immunocompetent; osteomyelitis; pediatric.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) Hip X-ray showed increased sclerosis with central lucency at the medial aspect of left femoral neck associated with the cortical irregularity and periosteal reaction; (B) Computed Tomography (CT) scan confirmed the erosive nature of the lesion with adjacent sclerosis and the adjacent bony overgrowth.
Figure 2
Figure 2
Magnetic Resonance Imaging (MRI) of the hip revealed bony overgrowth of the lesser trochanter with early cystic formation and a fluid-fluid level, extensive bone marrow edema, extensive adjacent soft tissue edema and hip joint effusion with evidence of synovial thickening and enhancement post contrast administration.
Figure 3
Figure 3
Histopathological findings in bone tissue (A) There are scattered bone trabeculae and fibroconnective tissue exhibiting dense inflammation and collection of hemosiderin-laden macrophages (lower left); (B) Collection of neutrophils forming micro-abscess.
Figure 4
Figure 4
(A) Pre-surgical X-ray showed worsening of medial femoral erosions and destruction with adjacent sclerosis; (B) Post-surgical X-ray demonstrated interval sclerosis and healing with new bone formation along the medial aspect of femoral neck with interval reduction of erosive changes and medial neck lytic lesion.

Similar articles

References

    1. Pastor F.J., Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin. Microbiol. Infect. 2006;12:948–960. doi: 10.1111/j.1469-0691.2006.01481.x. - DOI - PubMed
    1. Sprute R., Salmanton-García J., Sal E., Malaj X., Falces-Romero I., Hatvani L., Heinemann M., Klimko N., López-Soria L., Meletiadis J., et al. Characterization and outcome of invasive infections due to Paecilomyces variotii: Analysis of patients from the FungiScope® registry and literature reports. J. Antimicrob. Chemother. 2021;76:765–774. doi: 10.1093/jac/dkaa481. - DOI - PMC - PubMed
    1. Houbraken J., Verweij P.E., Rijs A.J., Borman A.M., Samson R.A. Identification of Paecilomyces variotii in clinical samples and settings. J. Clin. Microbiol. 2010;48:2754. doi: 10.1128/JCM.00764-10. - DOI - PMC - PubMed
    1. Luangsa-Ard J., Houbraken J., van Doorn T., Hong S.B., Borman A.M., Hywel-Jones N.L., Samson R.A. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS Microbiol. Lett. 2011;321:141–149. doi: 10.1111/j.1574-6968.2011.02322.x. - DOI - PubMed
    1. Batarseh R.Y., Shehata M., Becker M.D., Sigdel S., He P., Shweihat Y.R. Paecilomyces in an immune competent host. IDCases. 2020;21:e00885. doi: 10.1016/j.idcr.2020.e00885. - DOI - PMC - PubMed

Publication types

LinkOut - more resources